{
  "id": "semax",
  "name": "Semax",
  "type": "Nootropic",
  "category": "Cognitive Enhancement",
  "mechanism": "BDNF expression, NGF modulation, dopaminergic and serotonergic system enhancement, neuroprotection",
  "half_life": "~30 minutes (effects last hours)",
  "dosing": "300-600mcg, 1-3x daily",
  "administration": "Intranasal",
  "primary_benefits": [
    "Enhanced focus and concentration",
    "Memory improvement",
    "Neuroprotection",
    "Mood elevation",
    "Reduced cognitive fatigue",
    "Stress adaptation"
  ],
  "research_findings": "ACTH(4-10) analog. Developed in Russia. Well-studied for cognitive enhancement and neuroprotection",
  "system_targets": [
    "Neurological",
    "Cognitive"
  ],
  "accessibility": "Research peptide",
  "cost_tier": "low"
}